Guangyao Wu

Jilin University

Papers

1

Total Citations

11

H-Index

1

About

Dr. Guangyao Wu is pioneering the intersection of materials chemistry and clinical diagnostics, with a primary focus on developing advanced nanofiber platforms for liquid biopsy. His most notable contribution lies in the creation of dysprosium(III)-metal organic framework (MOF) nanofibers, designed to capture exosomes with high efficiency—a breakthrough that addresses the critical bottleneck of low throughput in conventional isolation methods like ultracentrifugation. This work, published in 2024 and already garnering 11 citations, holds transformative potential for biomarker discovery in liver disease, enabling more scalable and sensitive clinical analysis. Dr. Wu’s research thus bridges the gap between nanomaterials engineering and practical medical applications, offering a novel pathway for non-invasive disease monitoring. By harnessing the unique properties of lanthanide-based MOFs, he has opened new avenues for exosome-based diagnostics, positioning himself as a rising innovator in the field. His achievements underscore a commitment to translating fundamental materials science into tools that can directly impact patient care, making his work essential reading for researchers in nanomedicine, bioanalytical chemistry, and translational oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Preparation of Dysprosium(III)-Metal Organic Framework Nanofiber for Exosome Capture and Biomarker Discovery toward Liver Disease
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Jilin University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago